Navigation Links
Quality of Medicines Advanced by Agreement Between USP, Mexican Standards Body
Date:8/25/2009

ROCKVILLE, Md., Aug. 25 /PRNewswire-USNewswire/ -- Demonstrating a significant commitment to advancing the quality of medicines for patients on behalf of both countries, the U.S. Pharmacopeial (USP) Convention and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) today agreed to collaborate on the development of standards for medicines. These standards are a key component of public health, helping to ensure the identity, quality, purity, strength and consistency of medicines that patients rely on every day.

The Memorandum of Understanding (MOU), signed in Mexico City by Roger L. Williams, M.D., USP chief executive officer, and Pedro D. Castaneda Lopez, executive member of FEUM, specifies a number of areas of collaboration, including revising, updating and integrating monographs for medicines contained in both pharmacopeias; exchanging scientific and technical information through meetings, courses and conferences; and establishing joint reference materials, which are physical samples that ensure compliance to written pharmacopeial standards. A joint work group will be formed to develop priorities within the next month.

"International cooperation is critical to assuring the quality of medicines, particularly in the global manufacturing environment in which they are now produced," said Dr. Williams. "The importance of such an activity should not be understated, as patients deserve access to quality medicines that are pure, are of the appropriate and expected strength, and are consistent from one dose to the next -- regardless of where they live or where the medicines and their ingredients they take were manufactured. We look forward to expanding the scope of our work with FEUM through this Memorandum of Understanding."

"FEUM is very pleased to engage in this important partnership with USP," said Mr. Castaneda Lopez. "This agreement is another milestone in our relationship, which affects patients in Mexico, the United States and worldwide. We look forward to our future work on scientific and technical matters that contribute to quality medicines for all."

The agreement expands on activities in a previous MOU signed between USP and FEUM in October 1999.

For more information, please contact mediarelations@usp.org.

USP -- Advancing Public Health Since 1820

The United States Pharmacopeial (USP) Convention is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are recognized and used worldwide. For more information about USP visit http://www.usp.org. FY1006


'/>"/>
SOURCE U.S. Pharmacopeia
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Reuters Survey: Americans Skeptical that Healthcare Reform Will Improve Quality or Affordability
2. BryanLGH Health System Selects Clinical Xpert From Thomson Reuters to Improve Clinical Quality
3. MN Community Measurement Launches First-Of-Its-Kind Quality Measure For Depression Care
4. Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes
5. Sixteen Genesis HealthCare Centers Receive Prestigious Award for Continuous Quality Improvement in Long Term Care
6. Palliative care intervention for patients with advanced cancer provides quality of life benefits
7. MicroDynamics to Introduce New Microscope at Quality Expo
8. Ingenious Meds IM Quality(TM) Solution Goes Mobile
9. National Quality Forum Endorses Measures to Improve Medication Safety and Quality
10. Air Quality Action Day Declared for Tuesday, August 18, 2009
11. HCCA 2009 Fall National Compliance Conference Lineup to Focus on Quality of Care, Physician Practice Compliance, Research Compliance, and Health Care Fraud & Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: